Watanabe J. Reply to letters to the editor: Discordance in estrogen receptor and change of Ki67 between primary site and metastatic site of recurrent breast cancer. Breast Cancer Res Treat 2020 May 21. pii: 10.1007/s10549-020-05695.
PMID: 32441017